Targeting Wnt pathways in disease

Cold Spring Harbor Perspectives in Biology

Volumn 4, Issue 11, 2012, Pages

  Zimmerman, Zachary F ^a   Moon, Randall T ^a,b   Chien, Andy J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; APC PROTEIN, HUMAN; BETA CATENIN; CELL RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG EFFECT; DRUG THERAPY; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; PHYSIOLOGY; WNT SIGNALING PATHWAY;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CATENIN; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; DRUG THERAPY; HUMANS; NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; WNT SIGNALING PATHWAY;

EID: 84868537782     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a008086     Document Type: Article

References (207)

1. Agholme F, Li X, Isaksson H, Ke HZ, Aspenberg P. 2010. Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J Bone Miner Res 25: 2412-2418.
2. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA. 2005. Importance of P-cadherin, β-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cance Res 11: 8606-8614.
3. Bakre MM, Hoi A, Mong JC, Koh YY, Wong KY, Stanton LW. 2007. Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustaine Wnt pathway activation. J Biol Chem 282: 31703-31712.
4. Biechele TL, Moon RT. 2008. Assaying β-catenin/TCF transcription with β-catenin/TCF transcription-based reporter constructs. Methods in molecular biology, Vol. 468, pp. 99-110. Humana Press, Clifton, NJ.
5. Biechele TL, Camp ND, Fass DM, Kulikauskas RM, Robin NC, White BD, Taraska CM, Moore EC, Muster J, Karmachary R, et al. 2010. Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma. Chem Biol 17: 1177-1182.
6. Blackwood DHR, Fordyce A, Walker MT, St. Clair DM, Porteou DJ, Muir WJ. 2001. Schizophrenia and affective disorders-Cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: Clinical and P300 findings in a family. Am J Hum Genet 69: 428-433.
7. Bodine PVN, Zhao W, Kharode YP, Bex FJ, Lambert A-J, Goad MB, Gaur T, Stein GS, Lian JB, Komm BS. 2004. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol (Baltimore, Md) 18: 1222-1237.
8. Boon EM. J, Keller JJ, Wormhoudt TA. M, Giardiello FM, Offerhaus GJ. A, van der Neut R, Pals ST. 2004. Sulindac targets nuclear β-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. Brit J Cancer 90: 224-229.
9. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnic MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 1513-1521.
10. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, et al. 2001. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68: 577-589.
11. Bu G, Lu W, Liu C-C, Selander K, Yoneda T, Hall C, Kelle ET, Li Y. 2008. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases. Int J Cancer 123: 1034-1042.
12. Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM, Morton DG. 2004. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64: 883-888.
13. Cantrell VA, Jessen JR. 2010. The planar cell polarity protein Van Gogh-Like 2 regulates tumor cell migration and matrix metalloproteinase-dependent invasion. Cancer Lett 287: 54-61.
14. Cappuccio I, Calderone A, Busceti CL, Biagioni F, Pontarelli F, Bruno V, Storto M, Terstappen GT, Gaviraghi G, Forna F, et al. 2005. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. J Neurosci 25: 2647-2657.
15. Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G, Terstappen GC, Nicolett F. 2004. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J Neurosci 24: 6021-6027.
16. Carroll-Anzinger D, Kumar A, Adarichev V, Kashanchi F, Al-Harthi L. 2007. Human immunodeficiency virus-restricted replication in astrocytes and the ability of γ interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway. J Virol 81: 5864-5871.
17. Cheah PY, Choo PH, Yao J, Eu KW, Seow-Choen F. 2002. A survival-stratification model of human colorectal carcinomas with β-catenin and 27kip1. Cancer 95: 2479-2486.
18. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan C-W, Wei S, Hao W, Kilgore J, Williams NS, et al. 2009. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5: 100-107.
19. Chien AJ, Conrad WH, Moon RT. 2009a. A Wnt survival guide: Fromflies to human disease. J Invest Dermatol 129: 1614-1627.
20. Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL, Moon RT. 2009b. Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. ProcNat Acad Sci 106: 1193-1198.
21. Cirone P, Lin S, Griesbach HL, Zhang Y, Slusarski DC, Crew CM. 2008. A role for planar cell polarity signaling in angiogenesis. Angiogenesis 11: 347-360.
22. Clément-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssiére B, Belleville C, Estrera K, Warman ML, Baron R, Rawadi G. 2005. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci 102: 17406-17411.
23. Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlo RA, et al. 2011. Lrp5 functions in bone to regulate bone mass. Nat Med 17: 684-691.
24. Day TF, Guo X, Garrett-Beal L, Yang Y. 2005. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8: 739-750.
25. DeAlmeida VI, Miao L, Ernst JA, Koeppen H, Polakis P, Rubinfeld B. 2007. The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. Cancer Res 67: 5371-5379.
26. de Boer J, Siddappa R, Gaspar C, van Apeldoorn A, Fodde R, van Blitterswijk C. 2004. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34: 818-826.
27. De Ferrari GV, Moon RT. 2006. The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene 25: 7545-7553.
28. De Ferrari GV, Papassotiropoulos A, Biechele T, Wavrant De-Vrieze F, Avila ME, Major MB, Myers A, Sáez K, Henríquez JP, Zhao A, et al. 2007. Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc Natl Aca Sci 104: 9434-9439.
29. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecke C, et al. 2007. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156-163.
30. Ding Y, Shen S, Lino AC, Curotto de Lafaille MA, Lafaille JJ. 2008. β-Catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells. Nat Med 14: 162-169.
31. Dorsky RI, Raible DW, Moon RT. 2000. Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 14: 158-162.
32. Edamura K, Nasu Y, Takaishi M, Kobayashi T, Abarzua F, Sakaguchi M, Kashiwakura Y, Ebara S, Saika T, Watanab M, et al. 2007. Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model. Cancer Gene Ther 14: 765-772.
33. Elzagheid A, Buhmeida A, Korkeila E, Collan Y, Syrjanen K, Pyrhonen S. 2008. Nuclear β-catenin expression as a prognostic factor in advanced colorectal carcinoma. World J Gastroentero 14: 3866-3871.
34. Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguch M, MoonRT, Teo J-L, OhSW, KimHY, et al. 2004. A small molecule inhibitor of β-catenin/CREB-binding protein transcription. Proc Natl Acad Sci 101: 12682-12687.
35. Engler TA, Henry JR, Malhotra S, Cunningham B, Furness K, Brozinick J, Burkholder TP, Clay MP, Clayton J, Diefenbache C, et al. 2004. Substituted 3-imidazo[1,2-a]pyridin-3-yl-4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3. J Me Chem 47: 3934-3937.
36. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, et al. 2008. CDK8 is a colorectal cancer oncogene that regulates β-catenin activity. Nature 455: 547-551.
37. Ford CE, Ekström EJ, Howlin J, Andersson T. 2009. The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer. Cell Cycle (Georgetown, Tex) 8: 1838-1842.
38. Freyberg Z, Ferrando SJ, Javitch JA. 2010. Roles of the Akt/ GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiat 167: 388-396.
39. Fukui T, Kondo M, Ito G, Maeda O, Sato N, Yoshioka H, Yokoi K, Ueda Y, Shimokata K, Sekido Y. 2005. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-smallcell lung cancer. Oncogene 24: 6323-6327.
40. Fukukawa C, Hanaoka H, Nagayama S, Tsunoda T, Toguchid J, Endo K, Nakamura Y, Katagiri T. 2008. Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci 99: 432-440.
41. Fulciniti M, Tassone P, Hideshima T, Vallet S, Nanjappa P, Ettenberg SA, Shen Z, Patel N, Tai Y-T, Chauhan D, et al. 2009. Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma. Blood 114: 371-379.
42. Gamallo C, Palacios J, Moreno G, Calvo deMora J, Suárez A, Armas A. 1999. β-Catenin expression pattern in stage I and II ovarian carcinomas: Relationship with β-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 155: 527-536.
43. +memory stem cells. Nat Med 15: 808-813.
44. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. 1993. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328: 1313-1316.
45. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, et al. 2010. Subtypes of medulloblastoma have distinct developmental origins. Nature 468: 1095-1099.
46. Glantschnig H, Hampton RA, Lu P, Zhao JZ, Vitelli S, Huang L, Haytko P, Cusick T, Ireland C, Jarantow SW, et al. 2010. Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo. J Biol Chem 285: 40135-40147.
47. Glass DA II, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, et al. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751-764.
48. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, et al. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523.
49. Gonsalves FC, Klein K, Carson BB, Katz S, Ekas LA, Evans S, Nagourney R, Cardozo T, Brown AM. C, DasGupta R. 2011. An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci 108: 5954-5963.
50. Gottardi CJ, Gumbiner BM. 2004. Distinct molecular forms of β-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 167: 339-349.
51. Graham TA, Weaver C, Mao F, Kimelman D, Xu W. 2000. Crystal structure of a β-catenin/Tcf complex. Cell 103: 885-896.
52. Graham JA, Fray M, de Haseth S, Lee KM, Lian MM, Chase CM, Madsen JC, Markmann J, Benichou G, Colvin RB, et al. 2010. Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3β inhibition. J Bio Chem 285: 32852-32859.
53. Guettler S, Larose J, Petsalaki E, Gish G, Scotter A, Pawson T, Rottapel R, Sicheri F. 2011. Structural basis and sequence rules for substrate recognition by tankyrase explain the basis for cherubism disease. Cell 147: 1340-1354.
54. Gunn WG, Krause U, Lee N, Gregory CA. 2010. Pharmaceutical inhibition of glycogen-synthetase-kinase-3-β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model. Blood 117: 1641-1651.
55. He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, McCormick F, Jablons DM. 2004. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6: 7-14.
56. He B, Barg RN, You L, Xu Z, Reguart N, Mikami I, Batra S, Rosell R, Jablons DM. 2005a. Wnt signaling in stem cells and non-small-cell lung cancer. Clin Lung Cancer 7: 54-60.
57. He B, Reguart N, You L, Mazieres J, Xu Z, Lee AY, Mikami I, McCormick F, Jablons DM. 2005b. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 24: 3054-3058.
58. Heiser PW, Cano DA, Landsman L, Kim GE, Kench JG, Klimstra DS, Taketo MM, Biankin AV, Hebrok M. 2008. Stabilization of β-catenin induces pancreas tumor formation. Gastroenterology 135: 1288-1300.
59. HendersonWRJr, Chi EY, Ye X, Nguyen C, Tien Y-t, Zhou B, Borok Z, Knight DA, Kahn M. 2010. Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci 107: 14309-14314.
60. Hoeppner LH, Secreto FJ, Westendorf JJ. 2009. Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Targets 13: 485-496.
61. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL, Williams BO. 2005. Essential role of β-catenin in postnatal bone acquisition. J Biol Chem 280: 21162-21168.
62. Hornyak TJ, Hayes DJ, Chiu LY, Ziff EB. 2001. Transcription factors in melanocyte development: Distinct roles for Pax-3 and Mitf. Mech Dev 101: 47-59.
63. Horvath LG, Henshall SM, Lee C-S, Kench JG, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygie JJ, et al. 2005. Lower levels of nuclear β-catenin predict for a poorer prognosis in localized prostate cancer. Int J Cancer 113: 415-422.
64. Huang S-MA, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessne S, et al. 2009. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614-620.
65. Huber AH, Weis WI. 2001. The structure of the β-catenin/ E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell 105: 391-402.
66. Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, Smith JC, Krumlauf R. 2003. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 130: 4295-4305.
67. Jeannet G, Boudousquié C, Gardiol N, Kang J, Huelsken J, HeldW. 2010. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc Natl Acad Sci 107: 9777-9782.
68. Jensen M, Engert A, Weissinger F, Knauf W, Kimby E, Poynto C, Oliff IA, Rummel MJ, Osterborg A. 2008. Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia. Invest New Drugs 26: 139-149.
69. Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T. 2001. Loss of β-catenin expression associated with disease progression in malignant melanoma. Brit J Dermatol 145: 210-216.
70. Kameoka M, Kameoka Y, Utachee P, Kurosu T, Sawanpanyaler P, Ikuta K, Auwanit W. 2009. Short communication: RNA interference directed against Axin1 upregulates human immunodeficiency virus type 1 gene expression by activating the Wnt signaling pathway in HeLa-derive J111 cells. AIDS Res Hum Retroviruses 25: 1005-1011.
71. Kang DE, Soriano S, Xia X, Eberhart CG, De Strooper B, Zheng H, Koo EH. 2002. Presenilin couples the paired phosphorylation of β-catenin independent of axin: Implications for β-catenin activation in tumorigenesis. Cell 110: 751-762.
72. Katoh M. 2002. Strabismus (STB)/Vang-like (VANGL) gene family (Review). Int J Mol Med 10: 11-15.
73. Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, et al. 2009. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 16: 65-72.
74. Kho DH, Bae JA, Lee JH, Cho HJ, Cho SH, Seo Y-W, Ahn KY, Chung IJ, Kim KK. 2009. KITENIN recruits Dishevelled/ PKCd to form a functional complex and controls the migration and invasiveness of colorectal cancer cells. Gut 58: 509-519.
75. Kim SY, Dunn IF, Firestein R, Gupta P, Wardwell L, Repich K, Schinzel AC, Wittner B, Silver SJ, Root DE, et al. 2010. CK1epsilon is required for breast cancers dependent on β-catenin activity. PloS ONE 5: e8979.
76. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechni D. 1991. Identification of FAP locus genes from chromosome 5q21. Science (New York, NY) 253: 661-665.
77. Klein PS, Melton DA. 1996. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci 93: 8455-8459.
78. Komatsu DE, Mary MN, Schroeder RJ, Robling AG, Turne CH, Warden SJ. 2010. Modulation of Wnt signaling influences fracture repair. J Orthop Res 28: 928-936.
79. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H. 1998. Depletion of epithelial stemcell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19: 379-383.
80. Kulkarni NH, Onyia JE, Zeng Q, Tian X, Liu M, Hallada DL, Frolik CA, Engler T, Wei T, Kriauciunas A, et al. 2006. Orally bioavailable GSK-3α/β dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res 21: 910-920.
81. Kumar A, Zloza A, Moon RT, Watts J, Tenorio AR, Al-Harth L. 2008. Active β-catenin signaling is an inhibitory path-way for human immunodeficiency virus replication in peripheral blood mononuclear cells. J Virol 82: 2813-2820.
82. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W, Kikuchi A. 2006. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66: 10439-10448.
83. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Borie C, Duhamel O, Trousset M, Attali P. 1991. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101: 635-639.
84. Lavergne E, Hendaoui I, Coulouarn C, Ribault C, Leseur J, Eliat P-A, Mebarki S, Corlu A, Clément B, MussoO. 2011. Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin. Oncogene 30: 423-433.
85. Le MN, Chan JL-K, Rosenberg SA, Nabatian AS, Merriga KT, Cohen-Solal KA, Goydos JS. 2010. The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells. J Invest Dermatol 130: 2240-2249.
86. Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikam I, McCormick F, Jablons DM. 2004a. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 23: 6672-6676.
87. Lee JH, Park SR, Chay K-O, Seo Y-W, Kook H, Ahn KY, Ki YJ, Kim KK. 2004b. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 64: 4235-4243.
88. Lee JK, Bae JA, Sun EG, Kim HD, Yoon TM, Kim K, Lee JH, Lim SC, Kim KK. 2009. KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model. FEBS Lett 583: 711-717.
89. Lee S-H, Kim B, Oh MJ, Yoon J, Kim HY, Lee KJ, Lee JD, Choi K-Y. 2011. Persicaria hydropiper (L.) spach and its flavonoid components, isoquercitrin and isorhamnetin, activate the Wnt/β-catenin pathway and inhibit adipocyte differentiation of 3T3-L1 cells. Phytother Res 25: 1629-1635.
90. Lengerke C, Schmitt S, Bowman TV, Jang IH, Maouche-Chretien L, McKinney-Freeman S, Davidson AJ, Hammerschmid M, Rentzsch F, Green JBA, et al. 2008. BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell 2: 72-82.
91. Lengerke C, Grauer M, Niebuhr NI, Riedt T, Kanz L, Park IH, Daley GQ. 2009. Hematopoietic development from human induced pluripotent stem cells. Ann NY Aca Sci 1176: 219-227.
92. Lepourcelet M, Chen Y-NP, France DS, Wang H, Crews P, Petersen F, Bruseo C, Wood AW, Shivdasani RA. 2004. Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex. Cancer Cell 5: 91-102.
93. Levaot N, Voytyuk O, Dimitriou I, Sircoulomb F, Chandrakumar A, Deckert M, Krzyzanowski PM, Scotter A, Gu S, Janmohamed S, et al. 2011. Loss of tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. Cell 147: 1324-1339.
94. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, W D. 2005. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280: 19883-19887.
95. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D'Agosti D, Kurahara C, Gao Y, Cao J, Gong J, et al. 2008. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23: 860-869.
96. Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Ca J, Gao Y, Shalhoub V, Tipton B, Haldankar R, et al. 2009. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res 24: 578-588.
97. Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terraccian L, Jass JR. 2007. Prognostic significance of thewnt signalling pathway molecules APC, β-catenin and E-cadherin in colorectal cancer: A tissue microarray-based analysis. Histopathology 50: 453-464.
98. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørene VA. 2003. Reduced β-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res 9: 3383-3388.
99. Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, Newmark HL, Chadburn A, BertagnolliMM. 1998. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis 19: 87-91.
100. Mahmoudi T, Li VSW, Ng SS, Taouatas N, Vries RGJ, Mohamme S, Heck AJ, Clevers H. 2009. The kinase TNIK is an essential activator of Wnt target genes. EMBO J 28: 3329-3340.
101. Major MB, Roberts BS, Berndt JD, Marine S, Anastas J, Chung N, Ferrer M, Yi X, Stoick-Cooper CL, von Halle PD, et al. 2008. New regulators of Wnt/β-catenin signaling revealed by integrative molecular screening. Sci Signal 1: ra12.
102. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, Wang Y-C, Pulendran B. 2010. Activation of β-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science (New York, NY) 329: 849-853.
103. Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Dou MK, Tassa C, Berry EM, Soda T, Singh KK, et al. 2009. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3b/β-catenin signaling. Cell 136: 1017-1031.
104. Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C. 2007. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 117: 3248-3257.
105. Mazieres J, You L, He B, Xu Z, Lee AY, Mikami I, McCormic F, Jablons DM. 2005a. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene 24: 5396-5400.
106. Mazieres J, You L, He B, Xu Z, Twogood S, LeeAY, Reguart N, Batra S, Mikami I, Jablons DM. 2005b. Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Int J Cancer 117: 326-332.
107. Mikami I, You L, He B, Xu Z, Batra S, Lee AY, Mazieres J, Reguart N, Uematsu K, Koizumi K, et al. 2005. Efficacy of Wnt-1 monoclonal antibody in sarcoma cells. BMC Cancer 5: 53.
108. Milovanovic T, Planutis K, Nguyen A, Marsh JL, Lin F, Hop C, Holcombe RF. 2004. Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol 25: 1337-1342.
109. Minear S, Leucht P, Jiang J, Liu B, Zeng A, Fuerer C, Nusse R, Helms JA. 2010. Wnt proteins promote bone regeneration. Sci Transl Med 2: 29ra30.
110. Miyamoto S, Endoh Y, Hasebe T, Ishii G, Kodama K, Goy M, Ono M, Saitoh N, Chiba T, Ochiai A. 2004. Nuclear bcatenin accumulation as a prognostic factor in Dukes' D human colorectal cancers. Oncol Rep 12: 245-251.
111. Miyaoka T, Seno H, Ishino H. 1999. Increased expression of Wnt-1 in schizophrenic brains. Schizophr Res 38: 1-6.
112. Moore WJ, Kern JC, Bhat R, Commons TJ, Fukayama S, Goljer I, Krishnamurthy G, Magolda RL, Nogle L, Pitt K, et al. 2009. Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides. J Med Chem 52: 105-116.
113. Morris JP IV, Cano DA, Sekine S, Wang SC, Hebrok M. β-Catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest 120: 508-520.
114. Mudher A, Chapman S, Richardson J, Asuni A, Gibb G, Pollard C, Killick R, Iqbal T, Raymond L, Varndell I, et al. 2001. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogenactivated protein kinase and c-Jun terminal kinase. JNeurosci 21: 4987-4995.
115. Mukhopadhyay M, Gorivodsky M, Shtrom S, Grinberg A, Niehrs C, Morasso MI, Westphal H. 2006. Dkk2 plays an essential role in the corneal fate of the ocular surface epithelium. Development 133: 2149-2154.
116. Nakamura Y, Nawata M, Wakitani S. 2005. Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 167: 97-105.
117. Namkoong J, Shin S-S, Lee HJ, Mari{dotless}́n YE, Wall BA, Goydo JS, Chen S. 2007. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 67: 2298-2305.
118. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Hori A, Koyama K, Utsunomiya J, Baba S, Hedge P. 1991. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (New York, NY) 253: 665-669.
119. Nostro MC, Cheng X, Keller GM, Gadue P. 2008. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2: 60-71.
120. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Daml MV, Mehta S, Purbey PK, Joseph J, Galande S. 2010. Global regulator SATB1 recruits β-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol 8: e1000296.
121. Nusse R. 2008. Wnt signaling and stem cell control. Cell Res 18: 523-527.
122. Nusse R, Varmus HE. 1982. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109.
123. Okino K, Nagai H, Hatta M, Nagahata T, Yoneyama K, Oht Y, Jin E, Kawanami O, Araki T, Emi M. 2003. Up-regulation and overproduction of DVL-1, the human counterpart of the Drosophila dishevelled gene, in cervical squamous cell carcinoma. Oncol Rep 10: 1219-1223.
124. Ominsky MS, Vlasseros F, Jolette J, Smith SY, Stouch B, Doellgast G, Gong J, Gao Y, Cao J, Graham K, et al. 2010. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res 25: 948-959.
125. Padhi D, Jang G, Stouch B, Fang L, Posvar E. 2011. Singledose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 26: 19-26.
126. Paige SL, Osugi T, Afanasiev OK, Pabon L, Reinecke H, Murry CE. 2010. Endogenous Wnt/β-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PloS ONE 5: e11134.
127. Pálmer HG, González-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, et al. 2001. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol 154: 369-387.
128. Pan W, Choi S-C, Wang H, Qin Y, Volpicelli-Daley L, Swan L, Lucast L, Khoo C, Zhang X, Li L, et al. 2008. Wnt3amediated formation of phosphatidylinositol 4,5-bisphosphate regulatesLRP6phosphorylation. Science (NewYork, NY) 321: 1350-1353.
129. Phillips RKS, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, Wakabayashi N, Shen Y, Zimmerman S, Godio L, et al. 2002. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50: 857-860.
130. Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ, Koganti A, Zhu H, Robbins C, Makalowska I, Shin S-S, et al. 2003. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 34: 108-112.
131. Pukrop T. 2006. Wnt 5α signaling is critical for macrophageinduced invasion of breast cancer cell lines. Proc Nat Acad Sci 103: 5454-5459.
132. Qiang Y-W, Chen Y, Stephens O, Brown N, Chen B, Epstei J, Barlogie B, Shaughnessy JDJ. 2008. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: A potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood 112: 196-207.
133. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willer K, Hintz L, Nusse R, Weissman IL. 2003. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423: 409-414.
134. Rhee C-S, Sen M, Lu D, Wu C, Leoni L, Rubin J, Corr M, Carson DA. 2002. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21: 6598-6605.
135. Rijsewijk F. 1987. The Drosophila homology of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50: 649-657.
136. Robitaille J, MacDonald ML. E, Kaykas A, Sheldahl LC, Zeisler J, Dubé M-P, Zhang L-H, Singaraja RR, Guernsey DL, Zheng B, et al. 2002. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet 32: 326-330.
137. Rodda SJ, McMahon AP. 2006. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development (Cambridge, England) 133: 3231-3244.
138. Roh M-S, Seo MS, Kim Y, Kim SH, Jeon WJ, Ahn YM, Kan UG, Juhnn YS, Kim YS. 2007. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Exp Molec Med 39: 353-360.
139. Säfholm A, Leandersson K, Dejmek J, Nielsen CK, Villoutrei BO, Andersson T. 2006. A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. J Biol Chem 281: 2740-2749.
140. Salinas PC, Zou Y. 2008. Wnt signaling in neural circuit assembly. Annu Rev Neurosci 31: 339-358.
141. Saraswati S, AlfaroMP, Thorne CA, Atkinson J, Lee E, Youn PP. 2010. Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PloS ONE 5: e15521.
142. Schwartz AL, Malgor R, Dickerson E, Weeraratna AT, Slominski A, Wortsman J, Harii N, Kohn AD, Moon RT, Schwartz FL, et al. 2009. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Clin Cancer Res 15: 4114-4122.
143. Semënov M, Tamai K, He X. 2005. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 280: 26770-26775.
144. Sen M, Lauterbach K, El-Gabalawy H, Firestein GS, Corr M, Carson DA. 2000. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Nat Acad Sci 97: 2791-2796.
145. Sen M, Chamorro M, Reifert J, Corr M, Carson DA. 2001. Blockade of Wnt-5A/Frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 44: 772-781.
146. Sen M, Reifert J, Lauterbach K, Wolf V, Rubin JS, Corr M, Carson DA. 2002. Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum 46: 2867-2877.
147. Shafer B, Onishi K, Lo C, Colakoglu G, Zou Y. 2011. Vangl2 promotes Wnt/planar cell polarity-like signaling by antagonizing Dvl1-mediated feedback inhibition in growth cone guidance. Dev Cell 20: 177-191.
148. Shan J, Shi D-L, Wang J, Zheng J. 2005. Identification of a specific inhibitor of the dishevelled PDZ domain. Biochemistry 44: 15495-15503.
149. Sheng Y-J, Gao J-P, Li J, Han J-W, Xu Q, HuW-L, Pan T-M, Cheng Y-L, Yu Z-Y, Ni C, et al. 2011. Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Rheumatology (Oxford, England) 50: 682-688.
150. Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, Tolle K, Hoskins EE, Kalinichenko VV, Wells SI, Zor AM, et al. 2011. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470: 105-109.
151. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimur T, et al. 2000. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342: 1946-1952.
152. Stoick-Cooper CL, Weidinger G, Riehle KJ, Hubbert C, Majo MB, Fausto N, Moon RT. 2007. Distinct Wnt signaling pathways have opposing roles in appendage regeneration. Development (Cambridge, England) 134: 479-489.
153. Su L, Vogelstein B, Kinzler K. 1993. Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737.
154. Sue Ng S, Mahmoudi T, Li VSW, Hatzis P, Boersema PJ, Mohammed S, Heck AJ, Clevers H. 2010. MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway. Biol Chem 391: 171-180.
155. Sugimura R, Li L. 2010. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res C Embryo Today 90: 243-256.
156. Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, William LT. 2001. PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol 3: 628-636.
157. Surendran K, Schiavi S, Hruska KA. 2005. Wnt-dependent β-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J A Soc Nephrol 16: 2373-2384.
158. Suzuki H, Watkins DN, Jair K-W, Schuebel KE, Markowitz SD, Dong Chen W, Pretlow TP, Yang B, Akiyama Y, van Engeland M, et al. 2004. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36: 417-422.
159. Suzuki H, Toyota M, Carraway H, Caraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojim M, et al. 2008. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Brit J Cancer 98: 1147-1156.
160. Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, Kondo H, Takao T, Takada S. 2006. Monounsaturated fatty acid modification of Wnt protein: Its role in Wnt secretion. Dev Cell 11: 791-801.
161. Takahashi S, Watanabe T, Okada M, Inoue K, Ueda T, Takada I, Watabe T, Yamamoto Y, Fukuda T, Nakamura T, et al. 2011. Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer. Proc Natl Acad Sci 108: 4938-4943.
162. Takayama S, Rogatsky I, Schwarcz LE, Darimont BD. 2006. The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-β-catenin complex. J Biol Chem 281: 17856-17863.
163. Takeda K, Yasumoto K, Takada R, Takada S, Watanabe K, Udono T, Saito H, Takahashi K, Shibahara S. 2000. Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J Biol Chem 275: 14013-14016.
164. Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS, Jernigan KK, Meyers KC, Hang BI, Waterso AG, et al. 2010. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1a. Nat Chem Biol 6: 829-836.
165. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr. 2003. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349: 2483-2494.
166. Toledo EM, Inestrosa NC. 2010. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1δE9 mouse model of Alzheimer's disease. Mol Psychiatry 15: 228, 272-285.
167. 2bone marrow-derived cells with short-term multilineage hematopoietic reconstitution capacity. Stem Cells (Dayton, Ohio) 28: 1379-1389.
168. Tveita AA, Rekvig OP. 2011. Alterations in Wnt pathway activity in mouse serum and kidneys during lupus development. Arthritis Rheum 63: 513-522.
169. Ueki Y, Lin CY, Senoo M, Ebihara T, Agata N, Onji M, Sahek Y, Kawai T, Mukherjee PM, Reichenberger E, et al. 2007. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice. Cell 128: 71-83.
170. Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM. 2003a. Activation of the Wnt pathway in non small cell lung cancer: Evidence of dishevelled overexpression. Oncogene 22: 7218-7221.
171. Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterli BM, McCormick F, Jablons DM. 2003b. Wnt pathway activation in mesothelioma: Evidence of Dishevelled overexpression and transcriptional activity of β-catenin. Cancer Res 63: 4547-4551.
172. Ueno S, Weidinger G, Osugi T, KohnAD, Golob JL, Pabon L, Reinecke H, Moon RT, Murry CE. 2007. Biphasic role for Wnt/β-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci 104: 9685-9690.
173. Ueno K, Hirata H, Majid S, Chen Y, Zaman MS, Tabataba ZL, Hinoda Y, Dahiya R. 2011. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol Carcinogen 50: 449-457.
174. Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottar DP, Cumberledge S, Rubin JS. 2000. Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 275: 4374-4382.
175. Vijayaragavan K, Szabo E, Bossé M, Ramos-Mejia V, Moo RT, Bhatia M. 2009. Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell 4: 248-262.
176. Vincan E, Darcy PK, Smyth MJ, Thompson EW, Thoma RJ. S, Phillips WA, Ramsay RG. 2005. Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth. Differentiation 73: 142-153.
177. von Marschall Z, Fisher LW. 2010. Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling. Biochem Biophys Res Commun 400: 299-304.
178. Wang Y, Nakayama N. 2009. WNT and BMP signaling are both required for hematopoietic cell development from human ES cells. Stem Cell Res 3: 113-125.
179. Wang F-S, Ko J-Y, Lin C-L, Wu H-L, Ke H-J, Tai P-J. 2007. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats. Bone 40: 485-492.
180. Wang F-S, Ko J-Y, Yeh D-W, Ke H-C, Wu H-L. 2008. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology 149: 1793-1801.
181. Wang H, Hao J, Hong CC. 2011a. Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/β-catenin signaling. ACS Chem Biol 6: 192-197.
182. Wang W, Liu H, Wang S, Hao X, Li L. 2011b. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis. Cell Res 21: 730-740.
183. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM. 2002. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1: 279-288.
184. Wei W, Chua MS, Grepper S, So SK. 2009. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Cancer 8: 76.
185. Wei W, Chua M-S, Grepper S, So SK. 2011. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol Cancer 10: 16.
186. +progenitors and astrocytes during post-traumatic gliogenesis in the adult brain. Stem Cells (Dayton, Ohio) 28: 297-307.
187. Willert K, Brown JD, Danenberg E, Duncan AW, Weissma IL, Reya T, Yates JR III, Nusse R. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
188. Witze ES, Litman ES, Argast GM, Moon RT, Ahn NG. 2008. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science (New York, NY) 320: 365-369.
189. Wong SCC, Lo SFE, Lee KC, Yam JWP, Chan JK. C, Wend Hsiao WL. 2002. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol 196: 145-153.
190. Wortman B, Darbinian N, Sawaya BE, Khalili K, Amini S. 2002. Evidence for regulation of long terminal repeat transcription by Wnt transcription factor TCF-4 in human astrocytic cells. J Virol 76: 11159-11165.
191. Wu W, Glinka A, Delius H, Niehrs C. 2000. Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/ β-catenin signalling. Curr Biol 10: 1611-1614.
192. Xiao J-H, Ghosn C, Hinchman C, Forbes C, Wang J, Snide N, Cordrey A, Zhao Y, Chandraratna RAS. 2003. Adenomatous polyposis coli (APC)-independent regulation of β-catenin degradation via a retinoidXreceptor-mediated pathway. J Biol Chem 278: 29954-29962.
193. Yadav VK, Ryu J-H, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, et al. 2008. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135: 825-837.
194. Yamamoto H, Sakane H, Michiue T, Kikuchi A. 2008. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of β-catenin signaling. Dev Cell 15: 37-48.
195. Yamauchi K, Sumi T, Minami I, Otsuji TG, Kawase E, Nakatsuj N, Suemori H. 2010. Cardiomyocytes develop from anterior primitive streak cells induced by β-catenin activation and the blockage of BMP signaling in hESCs. Genes Cells 15: 1216-1227.
196. Yang J, Si T, Ling Y, Ruan Y, Han Y, Wang X, Zhang H, Kon Q, Li X, Liu C, et al. 2003a. Association study of the human FZD3 locus with schizophrenia. Biol Psychiatry 54: 1298-1301.
197. Yang K, Fan K, Kurihara N, Shinozaki H, Rigas B, Augenlich L, Kopelovich L, Edelmann W, Kucherlapati R, Lipkin M. 2003b. Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations. Carcinogenesis 24: 605-611.
198. Yip D, Le MN, Chan JL-K, Lee JH, Mehnert JA, Yudd A, Kempf J, Shih WJ, Chen S, Goydos JS. 2009. A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res 15: 3896-3902.
199. You L, He B, Xu Z, Uematsu K, Mazieres J, Fujii N, Mikami I, Reguart N, McIntosh JK, Kashani-Sabet M, et al. 2004a. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res 64: 5385-5389.
200. You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, et al. 2004b. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23: 6170-6174.
201. Yu Q, Sharma A, Sen JM. 2010. TCF1 and β-catenin regulate T cell development and function. Immunol Res 47: 45-55.
202. Zamani A, Omrani GR, Nasab MM. 2009. Lithium's effect on bone mineral density. Bone 44: 331-334.
203. Zhang Y, Yeh JR, Mara A, Ju R, Hines JF, Cirone P, Griesbac HL, Schneider I, Slusarski DC, Holley SA. 2006. A chemical and genetic approach to the mode of action of fumagillin. Chem Biol 13: 1001-1009.
204. Zhang Y, Appleton BA, Wiesmann C, Lau T, Costa M, Hannoush RN, Sidhu SS. 2009. Inhibition of Wnt signaling by Dishevelled PDZ peptides. Nat Chem Biol 5: 217-219.
205. Zhao D-M, Yu S, Zhou X, Haring JS, Held W, Badovinac VP, Harty JT, Xue H-H. 2010. Constitutive activation of Wnt signaling favors generation of memory CD8 T cells. J Immunol (Baltimore, MD, 1950) 184: 1191-1199.
206. +T cells depend on T cell factor 1. Immunity 33: 229-240.
207. Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA. 2005. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer 116: 584-591.